Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole

A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT)

(2020) Anat Stern et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study

(2020) Prithviraj Bose et al.   CLINICAL INFECTIOUS DISEASES

Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients

(2020) Palash Samanta et al.   CLINICAL INFECTIOUS DISEASES

Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center

(2020) Andrew M Borman et al.   MEDICAL MYCOLOGY

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

(2020) Christoph Zurl et al.   Journal of Fungi

Isavuconazole therapeutic drug monitoring during long-term treatment for chronic pulmonary aspergillosis

(2020) Chris Kosmidis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isavuconazole for the prophylaxis and treatment of invasive fungal disease: a single‐center experience

(2020) Christine A. Vu et al.   Transplant Infectious Disease

Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients

(2019) Lauren Fontana et al.   CLINICAL INFECTIOUS DISEASES

Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy

(2019) E Furfaro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of triazole therapeutic drug monitoring availability and timing

(2019) Erin K. McCreary et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment by posaconazole tablets did not reduced variability of posaconazole trough concentrations compared to posaconazole suspension

(2019) Elodie Gautier-Veyret et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal drugs: What brings the future?

(2019) Ruth Van Daele et al.   MEDICAL MYCOLOGY

A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation

(2019) N. Decembrino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

(2019) J Peter Donnelly et al.   CLINICAL INFECTIOUS DISEASES

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

(2019) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES

Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials

(2018) David Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole

(2018) Caitlin R Rausch et al.   CLINICAL INFECTIOUS DISEASES

Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?

(2018) Monica Fung et al.   CLINICAL INFECTIOUS DISEASES

Isavuconazole for treatment of rare invasive fungal diseases

(2018) Oliver A. Cornely et al.   MYCOSES

Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial

(2018) Bart Jan Kullberg et al.   CLINICAL INFECTIOUS DISEASES

Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases

(2018) Thomas Kaindl et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events

(2018) Felix Bongomin et al.   MYCOSES

Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study

(2018) Van Kieu et al.   Transplant Infectious Disease

Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial

(2017) Dimitrios P Kontoyiannis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Implementation of Isavuconazole in a Fluorescence-Based High-Performance Liquid Chromatography Kit Allowing Simultaneous Detection of All Four Currently Licensed Mold-Active Triazoles

(2017) René Jørgensen et al.   mSphere

Real-World Use – Isavuconazole at a Large Academic Medical Center

(2017) HabiBA Hassouna et al.   Open Forum Infectious Diseases

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

(2016) Johan A Maertens et al.   LANCET

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

(2016) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study

(2015) Oliver A. Cornely et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent

(2015) Marisa H. Miceli et al.   CLINICAL INFECTIOUS DISEASES

Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections

(2013) Alessandro Pasqualotto et al.   Infection and Drug Resistance